TOBI

This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Canada, Croatia, Cyprus, Estonia, Finland, France, Ireland, Israel, Italy, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, South Africa, Spain, Turkey, UK.

Active ingredients

The drug TOBI contains one active pharmaceutical ingredient (API):

1	Tobramycin UNII VZ8RRZ51VK - TOBRAMYCIN
	Tobramycin is an aminoglycoside antibiotic produced by Streptomyces tenebrarius. It acts primarily by disrupting protein synthesis leading to altered cell membrane permeability, progressive disruption of the cell envelope and eventual cell death. It is bactericidal at concentrations equal to or slightly greater than inhibitory concentrations.
	Read more about Tobramycin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
TOBI Podhaler Inhalation powder, hard capsule	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01GB01	Tobramycin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01G Aminoglycoside antibacterials → J01GB Other aminoglycosides
Discover more medicines within J01GB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	10066T, 10074F, 5442K
BR	Câmara de Regulação do Mercado de Medicamentos	526513030077514, 541519110016417
CA	Health Products and Food Branch	02239630, 02365154
EE	Ravimiamet	1553879, 1553880, 1553891
ES	Centro de información online de medicamentos de la AEMPS	10652002, 63689
FI	Lääkealan turvallisuus- ja kehittämiskeskus	003861, 586241
FR	Base de données publique des médicaments	60565723, 65832685
GB	Medicines & Healthcare Products Regulatory Agency	195371, 41252
IE	Health Products Regulatory Authority	88370, 88373, 88882
IL	מִשְׂרַד הַבְּרִיאוּת	4922, 6965
IT	Agenzia del Farmaco	034767018
JP	医薬品医療機器総合機構	6123700G1026
LT	Valstybinė vaistų kontrolės tarnyba	1061964, 1061965, 1061966
MT	Medicines Authority	MA1507/02201
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	161M2004
NL	Z-Index G-Standaard	14675595
NL	Z-Index G-Standaard, PRK	59986, 98248
NZ	Medicines and Medical Devices Safety Authority	15591, 9549
PL	Rejestru Produktów Leczniczych	100315203
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W68686001, W68686002, W68686003
TR	İlaç ve Tıbbi Cihaz Kurumu	8698856520685
US	FDA, National Drug Code	0078-0494, 0078-0630, 49502-346
ZA	Health Products Regulatory Authority	A40/20.1.1/0522